{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:36:02Z","timestamp":1785803762918,"version":"3.56.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      This prospective study evaluated the diagnostic performance of\n                      <jats:sup>68<\/jats:sup>\n                      Ga DOTA-Pentixafor PET\/CT in characterizing the functional properties and lateralization of aldosterone-producing and cortisol-producing adrenal cortical lesions. The contribution of Pentixafor PET\/CT to diagnosis and treatment planning was assessed in comparison with CT, MRI, and\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>\n                      Twenty-five patients with suspected benign functional adrenal cortical masses were included. All patients underwent whole-body imaging at 1 hour and delayed abdominal imaging at 2 hours following intravenous administration of\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG and\n                      <jats:sup>68<\/jats:sup>\n                      Ga DOTA-Pentixafor. Lesion SUVmax, LCRSUVmax, and LLRSUVmax values were analyzed and correlated with laboratory parameters, other imaging modalities, and postoperative clinical and pathologic outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      <jats:sup>68<\/jats:sup>\n                      Ga DOTA-Pentixafor PET\/CT demonstrated distinct focal uptake relative to the contralateral adrenal gland and liver parenchyma in 6\/6 (100%) patients with suspected PA, 5\/18 (27.7%) with suspected CS, and 1\/1 (100%) with suspected EAS. Among patients with focal uptake who underwent surgery, all PA (5\/5) and all CS (5\/5) cases were confirmed as adrenocortical adenomas, resulting in no false-positive findings (PPV 100%). However, due to 2 false-negative CS cases, pentixafor PET\/CT demonstrated an overall sensitivity of 83.3%, specificity of 100%, and accuracy of 85.7%. Thresholds of SUVmax &gt;15.11, LCRSUVmax &gt;1.74, and LLRSUVmax &gt;4.36 yielded sensitivities of 33.3%, 41.7%, and 41.7%, respectively, while maintaining 100% specificity. Clinical and biochemical improvement was observed in 100% (5\/5) of operated PA patients and 100% (5\/5) of operated CS patients. Follow-up of nonoperated patients is ongoing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      <jats:sup>68<\/jats:sup>\n                      Ga DOTA-Pentixafor PET\/CT is a valuable diagnostic and potentially therapeutic tool for benign functional adrenal cortical disorders such as PA, CS, and EAS, with the potential to establish a new standard in minimally invasive patient management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006405","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:00:25Z","timestamp":1775491225000},"page":"e422-e430","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Performance of 68Ga DOTA-Pentixafor PET\/CT in Benign Functional Adrenal Cortical Lesions"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3931-4261","authenticated-orcid":false,"given":"\u00d6mer F.","family":"\u015eahin","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8509-1583","authenticated-orcid":false,"given":"Zehranur","family":"Tosuno\u011flu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Health Sciences, Van Training and Research Hospital, Van, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-4538","authenticated-orcid":false,"given":"Rahime","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Binali Yildirim University, Meng\u00fccek Gazi Training and Research Hospital, Erzincan, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5709-7700","authenticated-orcid":false,"given":"Dilruba","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul Medeniyet University, G\u00f6ztepe Prof. Dr. S\u00fcleyman Yal\u00e7in City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2268-9606","authenticated-orcid":false,"given":"G\u00f6ksel","family":"Al\u00e7in","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Health Sciences, \u0130stanbul Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-8883","authenticated-orcid":false,"given":"Esra","family":"Arslan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Health Sciences, \u0130stanbul Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7622-7277","authenticated-orcid":false,"given":"Tevfik F.","family":"\u00c7ermik","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Acibadem Maslak Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2023.19100","article-title":"What Is Cushing syndrome?","volume":"331","author":"Voelker","year":"2024","journal-title":"JAMA"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"101490","DOI":"10.1016\/j.beem.2021.101490","article-title":"Updates in adrenal steroidogenesis inhibitors for Cushing\u2019s syndrome\u2013a practical guide","volume":"35","author":"Varlamov","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiology.184.3.1509049","article-title":"Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT","volume":"184","author":"Doppman","year":"1992","journal-title":"Radiology"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/qjmed\/92.11.643","article-title":"Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone-secreting adrenal adenomas","volume":"92","author":"Harper","year":"1999","journal-title":"QJM"},{"key":"R8-20260605","first-page":"299","article-title":"Primary hyperaldosteronism and adrenal incidentaloma: an argument for physiologic testing before adrenalectomy","volume":"41","author":"McAlister","year":"1998","journal-title":"Can J Surg"},{"key":"R9-20260605","first-page":"1029","article-title":"Determining aldosterone in the adrenal veins in order to establish uni- or bilateral aldosterone production in patients with primary hyperaldosteronism","volume":"151","author":"Freriks","year":"2007","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.surg.2009.11.020","article-title":"Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology","volume":"148","author":"Tresallet","year":"2010","journal-title":"Surgery"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12020-024-04042-5","article-title":"[18(F)]FDG-PET\/CT in adrenal lesions: diagnostic performance in different clinical settings","volume":"87","author":"Romanisio","year":"2025","journal-title":"Endocrine"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1242\/dev.101071","article-title":"Chemokine signaling in development and disease","volume":"141","author":"Wang","year":"2014","journal-title":"Development"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur J Cancer"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","article-title":"The intricate role of CXCR4 in cancer","volume":"124","author":"Chatterjee","year":"2014","journal-title":"Adv Cancer Res"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2967\/jnumed.121.261964","article-title":"Functional characterization of adrenocortical masses in nononcologic patients using (68)Ga-pentixafor","volume":"63","author":"Ding","year":"2022","journal-title":"J Nucl Med"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40336-025-00697-w","article-title":"68Ga-pentixafor PET\/CT predict the surgical outcome for the primary aldosteronism","volume":"13","author":"Lin","year":"2025","journal-title":"Clin Transl Imag"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/RLU.0000000000004244","article-title":"Usefulness of 68 Ga-pentixafor PET\/CT on diagnosis and management of Cushing syndrome","volume":"47","author":"Ding","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2174\/0113895575408753250904112417","article-title":"Recent development of CXCR4-targeted nuclear medicine research in adrenocortical tumors","volume":"25","author":"Wang","year":"2025","journal-title":"Mini Rev Med Chem"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2967\/jnumed.123.266061","article-title":"Clinical value of (68)Ga-pentixafor PET\/CT in subtype diagnosis of primary aldosteronism patients with adrenal micronodules","volume":"65","author":"Ding","year":"2024","journal-title":"J Nucl Med"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12020-025-04236-5","article-title":"CXCR4-directed PET with (68)Ga-pentixafor versus adrenal vein sampling for the diagnosis of unilateral primary aldosteronism","volume":"89","author":"Tan","year":"2025","journal-title":"Endocrine"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11307-024-01976-0","article-title":"(68)Ga-pentixafor PET\/CT Is a supplementary method for primary aldosteronism subtyping compared with adrenal vein sampling","volume":"27","author":"Yi","year":"2025","journal-title":"Mol Imaging Biol"},{"key":"R24-20260605","first-page":"267","article-title":"Preliminary study on the ability of (68)Ga-Pentixafor PET\/CT to differentiate between adrenal aldosterone-producing adenoma and nonfunctional adenoma","volume":"62","author":"Gao","year":"2023","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R25-20260605","first-page":"100384","article-title":"(68)Ga-pentixafor PET\/CT in guiding surgical management of primary aldosteronism","volume":"39","author":"Zheng","year":"2025","journal-title":"J Clin Transl Endocrinol"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13550-025-01242-6","article-title":"The prognostic value of CXCR4 PET\/CT imaging in unilateral primary aldosteronism patients after adrenalectomy","volume":"15","author":"Shao","year":"2025","journal-title":"EJNMMI Res"},{"key":"R27-20260605","doi-asserted-by":"crossref","first-page":"e060779","DOI":"10.1136\/bmjopen-2022-060779","article-title":"CXCR4-directed [(68)Ga]Ga-PentixaFor PET\/CT versus adrenal vein sampling performance: a study protocol for a randomised two-step controlled diagnoStic Trial Ultimately comparing hypertenSion outcome in primary aldosteronism (CASTUS)","volume":"12","author":"Chaman Baz","year":"2022","journal-title":"BMJ Open"},{"key":"R28-20260605","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cen.15204","article-title":"Clinical utility of dual-time (68)Ga-pentixafor PET\/CT in diagnosing and subtyping primary aldosteronism","volume":"102","author":"Zuo","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R29-20260605","doi-asserted-by":"crossref","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","article-title":"Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism","volume":"6","author":"Hu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R30-20260605","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1007\/s00259-025-07244-9","article-title":"Total or partial adrenalectomy for aldosterone-producing adenoma: can (68)Ga-Pentixafor PET\/CT predict surgical outcomes?","volume":"52","author":"Zheng","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R31-20260605","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13550-025-01309-4","article-title":"Is CXCR4-targeted (68)Ga-pentixafor PET\/CT a reliable AVS-free modality for surgical decision-making and prognostic prediction in primary aldosteronism with bilateral adrenal lesions?","volume":"15","author":"Shu","year":"2025","journal-title":"EJNMMI Res"},{"key":"R32-20260605","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13550-024-01125-2","article-title":"Clinical value of (68)Ga-pentixafor PET\/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study","volume":"14","author":"Zuo","year":"2024","journal-title":"EJNMMI Res"},{"key":"R33-20260605","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12020-024-04059-w","article-title":"Benign pure androgen-secreting adrenal tumor misdiagnosed as adrenocortical carcinoma on (18)F-FDG PET-CT: a rare case report","volume":"87","author":"Wang","year":"2025","journal-title":"Endocrine"},{"key":"R34-20260605","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.semnuclmed.2025.05.001","article-title":"Advances in endocrine tumor PET imaging targeting CXCR4 and GLP-1","volume":"55","author":"Mena","year":"2025","journal-title":"Semin Nucl Med"},{"key":"R35-20260605","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.rcl.2025.03.014","article-title":"Nuclear imaging in the assessment of adrenal tumors","volume":"63","author":"McPhedran","year":"2025","journal-title":"Radiol Clin North Am"},{"key":"R36-20260605","doi-asserted-by":"crossref","first-page":"112240","DOI":"10.1016\/j.ejrad.2025.112240","article-title":"Performance of Pentixafor PET\/CT in identifying unilateral primary aldosteronism: a meta-analysis","volume":"190","author":"Gege","year":"2025","journal-title":"Eur J Radiol"},{"key":"R37-20260605","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13550-024-01194-3","article-title":"(68)Ga-Pentixafor PET\/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism","volume":"15","author":"Li","year":"2025","journal-title":"EJNMMI Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T20:00:23Z","timestamp":1780689623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006405","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"2025-12-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}